Skip to content
All Insights

Patient support

When patient support becomes part of treatment.

Yogesh Verma on why software that shapes a treatment experience needs clinical evidence, controlled changes, and earlier collaboration across teams.

A summary of the linked source.

Yogesh Verma asks where patient support ends and the treatment experience begins. Reflecting on the FDA’s prescription drug use-related software guidance, he considers how tools that respond to symptoms, suggest next steps, or adapt information may influence more than engagement.

His argument is that evaluating these experiences requires more than usability metrics. Teams also need to examine the evidence behind the guidance, the clinical suitability of decision logic, control of software updates, and clear responses to uncertainty—including when to involve a person.

For patient support programs, he advocates bringing technology teams into the planning process alongside medical, legal, regulatory, and patient-experience colleagues. Patients move through a connected treatment experience across apps, messages, websites, and human support. The software should be considered while that experience is being defined, rather than selected after the program has already been designed.

Explore the technology behind this perspective.

Explore HXT’s healthcare solutions